Podcasts about tress capital

Steve Peterson, WasteTrakr, CEO and Co-Founder Steve Peterson is the CEO and Co-Founder of WasteTrakr Technologies, a software application for ESG reporting and sustainability. In addition, Steve is a Partner at Tress Capital, a NY venture capital firm investing in cannabis technologies. Steve combines 20+ years of technology experience with five years of cannabis industry management experience as a VP/GM of retail operations in San Jose, Eugene and Portland OR. Steve has also assisted public companies with their growth strategies and is a Board Member of MedicateOH. www.WasteTrakr.com www.TressDeals.com www.Tress.io @CannaWasteTrakr https://www.linkedin.com/company/19035973/ Learn more about your ad choices. Visit megaphone.fm/adchoices

Join the smoke session and hang out with the Fantasy Football Hustler and special guest David Hess.David Hess is an entrepreneur, a medical cannabis enthusiast and a 2x cancer survivor with an amazing story!David is the Co-Founder and President of Tress Capital a company who seeks to generate strong risk-adjusted financial returns and social impact focused on responsible investments in the cannabis industry.Come join in on the smoke sesh!Follow the Fantasy Football Hustler on all platforms!

David Hess is today's featured Cannabis Investor.The HempTown USA Cannabis Investor Series is back for the third year.  This year, the Series is featuring eighteen of the cannabis industry's top investors who review the previous 12-months and share their 2021 investment strategies.  On today's episode Dan Humiston is joined by David Hess from Tress Capital.Produced By MJBulls

David is President at Tress Capital, an established investment management firm in the cannabis sector, founded in 2013. Tress originates, guides, and manages investment for HNW, SFO, and institutional clients in both fund and bespoke SMA vehicles. Tress works closely with its companies and sector as an active value-add investor. Its portfolio includes industry leaders such as SC Labs, Headset, Baker Technologies, Cannabis Now, Infusion Biosciences, Grownetics and North Bud Farms. A two time cancer survivor, David was introduced to the vast benefits of medical cannabis while undergoing cancer treatments in 2001 and again in 2003. David has since dedicated himself to furthering research, awareness, and business opportunities in the expanding cannabis industry.

Investor overcomes cancer, twice!Many people in the cannabis industry today were first introduced to the vast benefits of medical cannabis while undergoing cancer treatments. David Hess, a two-time cancer survivor believes that cannabis saved his life and has now dedicated himself to furthering research, awareness, and business opportunities in the expanding cannabis industry. He joins Osiris Stephen and Nina Simmons to share the story of his journey and to talk about Tress Capital a company that he co-funded to help other cannabis entrepreneurs finance their dreams.Produced By PodConX

Investor overcomes cancer, twice!Many people in the cannabis industry today were first introduced to the vast benefits of medical cannabis while undergoing cancer treatments.   David Hess, a two-time cancer survivor believes that cannabis saved his life and has now dedicated himself to furthering research, awareness, and business opportunities in the expanding cannabis industry.  He joins Osiris Stephen and Nina Simmons to share the story of his journey and to talk about Tress Capital a company that he co-funded to help other cannabis entrepreneurs finance their dreams.Produced By MJBulls

The Cannabis Business Coach Michael Zaytsev interviews and coaches David Hess, President & Co-Founder of Tress Capital, one of the first private investment firms dedicated exclusively to the Cannabis industry. David shares his riveting personal story of going from a Cannabis enthusiast in high school who collected signatures for California's Prop 215 campaign, to taking bong hits outside of Memorial Sloan Kettering while receiving chemotherapy as a cancer patient, to Cannabis industry deal maker and investor. We discuss the qualities an entrepreneur must possess to succeed in Cannabis business, David's pet peeves when being pitched by entrepreneurs, his advice for green entrepreneurs and investors, and some of David's favorite investments that he's made. In the coaching portion, we dance with work-life balance and Mike Z helps David overcome his natural workaholic tendencies to make time for restorative self-care.

The annual Cannabis Investor Spotlight Series presented by Integrated CBD, is back for the second year.   The series features twelve of the leading cannabis investors, sharing their 2020 investment strategies.  On today's episode the 'Spotlight' is shinning on David Hess from Tress Capital Produced By MJBulls Media | Cannabis Podcast Network Sponsored by Integrated CBD 

"Cannabis Investor Spotlight" Series shines on Tress Capital co-founder David Hess and his journey from cancer survivor to cannabis venture capitalist. Tress Capital's thoughtful, ethical approach to matching the correct investors to the correct cannabis entrepreneur sets them apart. David talks about the type of companies and investors that they like to work with. Learn more about Tress Capital at MJBulls.comProduced By MJBulls Media | Cannabis Podcast Network

Asher Troppe, Co-Founder and CEO of Tress Capital, on Jeff Sessions and the Trump administration reversing Obama's hands-off marijuana policy and how cannabis stocks will fare.Shira Ovide, Bloomberg Gadfly columnist covering technology, on Apple’s exposure to the chip flaw, and how the company’s efforts to make amends could be bad for business. Tom Gimbel, CEO of staffing firm LaSalle Network, on jobs data, and how CEOs are confident and hiring. Anna Edney, health care reporter for Bloomberg, on how the plan to slash US drug costs leans on problem-plagued factories.

We usually ask our guests the best things a cannabis startup founder should do when trying to raise money. But do you know what you should NEVER do? Find out in this week's episode with Tress Capital CEO and Cannabis Investor Asher Troppe. Asher also talks to Brandon about how he and his co-founder built an institutional grade investment management platform for the cannabis market, what the appointment of Jeff Sessions as Attorney General means for the industry, the Cannabis Scene in New York, and much more. Tune in, Listen up, Get Acquainted! Follow iC: TWITTER: https://twitter.com/cannabispod FACEBOOK: https://www.facebook.com/iCwebshow/ Learn More & Subscribe: http://investingincannabis.tv/ Contact us with any questions, thoughts, ideas for our show here: investingincannabis@gmail.com

Medical marijuana is big business. Or at least it’s going to be. Think back to what happened to the alcohol industry once prohibition was lifted. Many companies sprang up overnight and the financial boom it was for smart investors was unheard of. The medical marijuana industry is poised to present a similar opportunity - only this time it offers an additional bonus - the use of cannabis as medicine is truly helping people (unlike alcohol). On this episode, Jonathan Twombly chats with Asher Troppe of Tress Capital about the opportunities that exist now and others that are coming as cannabis is becoming legal across the United States and even the world. Isn’t it just pot? Or is there really such a thing as medical marijuana? It’s easy to be skeptical about something that has come on the scene as quickly as the legalization of marijuana has. And with recreational use being pushed forward right alongside the medicinal uses it’s no wonder the average American is slow to accept the idea. But research and actual case studies are showing significant medical uses for marijuana that can’t be denied and those who are interested in investing in things that truly help others have an opportunity to both help and profit financially at the same time. This episode unpacks the legal and medical issues and paints a great picture of the opportunities that exist for savvy investors. Many medicinal cannabis related companies are already thriving. Every state in the United States has its own laws and guidelines for the use and production of medicinal cannabis, but it’s only a matter of time before common standards are created and enforced regarding the potency and use of it as medicine. The State of California has already passed a law that will soon require laboratory verification of the potency of medicinal marijuana. There are already companies that conduct lab testing to determine THC levels in medicinal cannabis - and they only serve about 5% of the medicinal market at this time. What’s going to happen when the regulations go into effect? Those companies will boom. The good news is, your investments could too. Find out more on this episode of Capital Gains. Tress Capital exclusively invests in medicinal marijuana based companies. It stands to reason that as regulation and law begin to legitimize the use of marijuana as a medicine that investment companies will step in to provide funding for the cannabis related companies out there and opportunities for investors. Tress Capital is one of those investment companies and on this episode you’ll get to hear from co-founder Asher Troppe about how Tress Capital is carefully positioning itself as one of the leading investment firms in the industry - and doing so from the standpoint of credibility and trust. It’s a great and revealing conversation. Where is the cannabis industry headed in the next 5 years? It’s impossible for anyone to predict exactly what will happen in any industry. Investment forecasters have proven that to be true over the years. But all signs point to rapid and continued growth for the cannabis industry for the foreseeable future. With legalization spreading across the U.S. and more effective regulations coming into place each year, the need for companies and capital in the industry are going to become more and more in demand. Find out how you can get in on this growing industry at almost the ground floor, on this episode of Capital Gains. Outline of This Episode [1:52] Who is Asher Troppe? [3:01] The legal issue currently surrounding cannabis use. [3:34] Comparing legal usage numbers to medical usage numbers. [5:07] How cannabis is being used medicinally these days. [9:15] How are cannabis dosages regulated when used medicinally? [11:38] Where is the marijuana sourced for medicinal products? [15:11] The state of the U.S. banking industry as it relates to cannabis financing. [19:52] Asher’s background and how he got into this field. [27:01] How you can personally research this issue. [28:08] What Tress Capital is investing in. [39:15] How Tress Capital is institutionalizing their approach. [43:49] Asher’s view of where the cannabis industry is going in the next 5 years. [48:08] What’s on the horizon for Tress Capital? [49:45] Advice for those wanting to invest with a capital group like Tress Capital. [51:29] How a company in the cannabis industry should approach Tress Capital. Resources & People Mentioned Tress Capital The Cole Memo SC Labs www.TwoBridgesMgmt.com www.TheMortarBlog.com Connect With Capitalism.com Website: http://capitalism.com/ On Youtube On Facebook On Twitter On Youtube On LinkedIn